Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 298-309

  Ellestad, Kristofor K ^a   Tsutsui, Shigeki ^b   Noorbakhsh, Farshid ^a   Warren, Kenneth G ^a   Yong, V Wee ^b   Pittman, Quentin J ^b   Power, Christopher ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; B7 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; NEUROPROTECTIVE AGENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPINAL CORD; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; COCULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; FEMALE; GENETICS; HOSPITALIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; NEWBORN; PATHOLOGY;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; NEUROPROTECTIVE AGENTS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY;

EID: 68949116243     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803576     Document Type: Article

References (40)

1. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 911-920.
2. Strachan, D. P. 1989. Hay fever, hygiene, and household size. Br. Med. J. 299: 1259-1260.
3. Leibowitz, U., A. Antonovsky, J. M. Medalie, H. A. Smith, L. Halpern, and M. Alter. 1966. Epidemiological study of multiple sclerosis in Israel: II. Multiple sclerosis and level of sanitation. J. Neurol. Neurosurg. Psychiatry. 29: 60-68.
4. Correale, J., and M. Farez. 2007. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 61: 97-108.
5. La Flamme, A. C., K. Ruddenklau, and B. T. Backstrom. 2003. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 71: 4996-5004.
6. Sewell, D., Z. Qing, E. Reinke, D. Elliot, J. Weinstock, M. Sandor, and Z. Fabry. 2003. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int. Immunol. 15: 59-69.
7. Gruden-Movsesijan, A., N. Ilic, M. Mostarica-Stojkovic, S. Stosic-Grujicic, M. Milic, and L. Sofronic-Milosavljevic. 2008. Trichinella spiralis: modulation of experimental autoimmune encephalomyelitis in DA rats. Exp. Parasitol. 118: 641-647.
8. Zorzella, S. F., J. Seger, D. R. Martins, A. C. Pelizon, and A. Sartori. 2007. Resistance to experimental autoimmune encephalomyelitis development in Lewis rats from a conventional animal facility. Mem. Inst. Oswaldo Cruz 102: 931-936.
9. Goverman, J., A. Woods, L. Larson, L. P. Weiner, L. Hood, and D. M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551-560.
10. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
11. Anderton, S. M., and R. S. Liblau. 2008. Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system. Curr. Opin. Neurol. 21: 248-254.
12. Paul, W. E. 2003. Fundamental Immunology, 5th Ed. Lippincott Williams & Wilkins, Philadelphia, pp. 497-517.
13. Pasare, C., and R. Medzhitov. 2005. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560: 11-18. (Pubitemid 43759170)
14. Romagnani, S. 2006. Regulation of the T cell response. Clin. Exp. Allergy 36: 1357-1366.
15. Kamradt, T., R. Goggel, and K. J. Erb. 2005. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol. 26: 260-267.
16. Cabre, P. 2007. Migration and multiple sclerosis: the French West Indies experience. J. Neurol. Sci. 262: 117-121.
17. Spencer, S. J., S. Martin, A. Mouihate, and Q. J. Pittman. 2006. Early-life immune challenge: defining a critical window for effects on adult responses to immune challenge. Neuropsychopharmacology 31: 1910-1918.
18. Noorbakhsh, F., S. Tsutsui, N. Vergnolle, L. A. Boven, N. Shariat, M. Vodjgani, K. G. Warren, P. Andrade-Gordon, M. D. Hollenberg, and C. Power. 2006. Proteinase- activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203: 425-435.
19. Tsutsui, S., J. Schnermann, F. Noorbakhsh, S. Henry, V. W. Yong, B. W. Winston, K. Warren, and C. Power. 2004. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J. Neurosci. 24: 1521-1529.
20. Giuliani, F., L. M. Metz, T. Wilson, Y. Fan, A. Bar-Or, and V. W. Yong. 2005. Additive effect of the combination of glatiramer acetate and minocycline in a model of MS. J. Neuroimmunol. 158: 213-221.
21. Tsutsui, S., F. Noorbakhsh, A. Sullivan, A. J. Henderson, K. Warren, K. Toney-Earley, S. E. Waltz, and C. Power. 2005. RON-regulated innate immunity is protective in an animal model of multiple sclerosis. Ann. Neurol. 57: 883-895.
22. Power, C., P. A. Kong, T. O. Crawford, S. Wesselingh, J. D. Glass, J. C. McArthur, and B. D. Trapp. 1993. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann. Neurol. 34: 339-350.
23. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747.
24. Trapp, B. D., J. Peterson, R. M. Ransohoff, R. Rudick, S. Mork, and L. Bo. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338: 278-285.
25. Tzartos, J. S., M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger. 2008. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172: 146-155.
26. Buenafe, A. C., and D. N. Bourdette. 2007. Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 182: 32-40.
27. + cells. J. Immunol. 175: 959-966.
28. Hansen, B. S., R. Z. Hussain, A. E. Lovett-Racke, J. A. Thomas, and M. K. Racke. 2006. Multiple Toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity. J. Neuroimmunol. 172: 94-103.
29. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Backstrom, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.
30. + regulatory T lymphocytes through the induction of anergy and infectious tolerance. J. Immunol. 180: 2830-2838.
31. Huang, Y. M., M. Kouwenhoven, Y. P. Jin, R. Press, W. X. Huang, and H. Link. 2001. Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression. Mult. Scler. 7: 95-99.
32. + cells identify them as a subset of NK cells. J. Exp. Med. 204: 2561-2568.
33. Ouabed, A., F. X. Hubert, D. Chabannes, L. Gautreau, M. Heslan, and R. Josien. 2008. Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells. J. Immunol. 180: 5862-5870.
34. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
35. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer. 2004. Species-specific recognition of single- stranded RNA via Toll-like receptor 7 and 8. Science 303: 1526-1529.
36. Koski, G. K., K. Kariko, S. Xu, D. Weissman, P. A. Cohen, and B. J. Czerniecki. 2004. Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J. Immunol. 172: 3989-3993.
37. Giovannoni, G., and G. Ebers. 2007. Multiple sclerosis: the environment and causation. Curr. Opin. Neurol. 20: 261-268.
38. Gavin, M. A., T. R. Torgerson, E. Houston, P. DeRoos, W. Y. Ho, A. Stray-Pedersen, E. L. Ocheltree, P. D. Greenberg, H. D. Ochs, and A. Y. Rudensky. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103: 6659-6664.
39. Weber, M. S., T. Prod'homme, S. Youssef, S. E. Dunn, C. D. Rundle, L. Lee, J. C. Patarroyo, O. Stuve, R. A. Sobel, L. Steinman, and S. S. Zamvil. 2007. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 13: 935-943.
40. Liu, Y., I. Teige, B. Birnir, and S. Issazadeh-Navikas. 2006. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 12: 518-525.